Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Sales Income and Research and Development Costs for FDA-Approved Cancer Drugs Sold by Originator Drug Companies.

JAMA network open·2019
Same author

The drugs don't work: WHO's role in advancing new antibiotics.

Lancet (London, England)·2018
Same author

Value-Based Pricing: L'Enfant Terrible?

PharmacoEconomics·2017
Same author

Clarifying WHO's position on the FRAX® tool for fracture prediction.

Bulletin of the World Health Organization·2016
Same author

Cost-effectiveness thresholds: pros and cons.

Bulletin of the World Health Organization·2016
Same author

Expensive medicines: ensuring objective appraisal and equitable access.

Bulletin of the World Health Organization·2015
Same journal

Therapeutic activation of PPARα contributes to NOTCH1 inhibition in T-cell acute lymphoblastic leukemia.

BMC medicine·2026
Same journal

Social vulnerability index and inflammation: a proteomic analysis linking social context to biological risk in older black adults.

BMC medicine·2026
Same journal

Efficacy of remote ischemic conditioning on cerebral blood flow regulation in patients with endovascular stenting: a randomized controlled trial.

BMC medicine·2026
Same journal

Brief digital narrative intervention for adolescent depression, anxiety, and insomnia during academic stress: a cluster randomized controlled trial.

BMC medicine·2026
Same journal

Effect of Vitamin C on bleeding and pain after kidney biopsy: a randomized controlled trial.

BMC medicine·2026
Same journal

Impact of gestational diabetes on future diabetic retinopathy and microvascular complications: a nationwide cohort study.

BMC medicine·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Cost-effectiveness analysis for clinicians.

Suzanne R Hill1

  • 1World Health Organization, 20 Ave Appia, Geneva 27, Switzerland. suzannerhill@gmail.com

BMC Medicine
|February 3, 2012
PubMed
Summary
This summary is machine-generated.

Cost-effectiveness analysis aids health care decisions amid economic uncertainty. Careful interpretation and individual patient data are crucial for unbiased, personalized choices.

Related Experiment Videos

Last Updated: May 25, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

Area of Science:

  • Health Economics
  • Decision Science

Background:

  • Economic uncertainty necessitates efficient health care resource allocation.
  • Cost-effectiveness analysis (CEA) is a key tool for evaluating health interventions.

Purpose of the Study:

  • To highlight the importance of CEA in health care decision-making.
  • To emphasize the need for careful interpretation and potential biases in CEA results.
  • To advocate for individualized considerations within CEA frameworks.

Main Methods:

  • Review of established methods for cost-effectiveness analysis.
  • Discussion of interpretation challenges and biases in CEA.
  • Exploration of threshold setting in decision-making.

Main Results:

  • CEA methods are established but require cautious interpretation due to potential biases.
  • Decision-making using CEA may involve setting cost-effectiveness thresholds.
  • Quality-adjusted life year (QALY) metrics need disaggregation for individual benefit-harm assessment.

Conclusions:

  • CEA is valuable but not infallible; careful application is essential.
  • Individual patient preferences and circumstances must be integrated into CEA for equitable decision-making.
  • Disaggregating benefits and harms within QALYs is vital for personalized health care choices.